 |
EUROPABIO OPEN DAY, 14 JUNE 2007
Don't miss keynote speaker EU Trade Commissioner
Peter Mandelson.
For more information and to register for an invitation, click
here
|
EuropaBio congratulates European
Parliament on Advanced Therapies Regulation
The European Parliament voted, in a land mark vote,
for an EU Regulation on Advanced Therapies that if
adopted by the Council, will pave the way for truly
innovative, safe regenerative medicines for patients
and for a regulatory framework that offers certainty
and predictability for Europe’s biotechnology-based
companies. EuropaBio has made significant
contributions to this process and warmly welcomes
this first step in the right direction.
For more information, see
EuropaBio's
press release.
European Commission releases a
Communication on the Mid-Term Policy Review
Last month, the
EU
Commission issued a Communication on biotechnology – the
Mid-Term Policy Review of the EU's Life Science and
Biotechnology Strategy. The Review assesses what needs
to change in the strategy, what new policies are
required, what has worked and what has not worked so
well in developing the biotechnology environment in
Europe.
For more information, please see the
EU Commission
Press Release
or see
EuropaBio's press release.
The Joint
Research Council's BIO4EU Study
In
April, the EU published the Bio4EU study “Consequences,
opportunities and challenges of modern biotechnology”
which was carried out by the Joint Research Centre (the
Research Centre of the European Commission).
The landmark study gives extensive facts and figures of the
biotech industry in Europe.
For
more information, please click
here or see
EuropaBio's press release.
Match2Bio website launched
Match2BioSME is a European FP6 initiative
with the mission to stimulate innovation in the European
biotechnology industry by matching activities of small-
and medium sized companies (SMEs) with academic
institutions.
For more information, see
The Match2Bio website
EuropaBio's Green Biotech Europe Country Leaders meet in Brussels
The working
sessions focused on the approval process and the importance of lobbying for MS
support for the EFSA opinions and labelling thresholds for
adventitious presence of GM in non-GM seed.
For more information please contact EuropaBio's
Nathalie Moll.
Party of European Socialists support white biotechnology
The Party of European
Socialists (PES) invited
EuropaBio
and industry representatives to an
event on eco-innovation in March to discuss
input into an internal discussion process on smart,
green growth strategy and ecological industrial policy.
The meeting revealed the support that white
biotech has from the PES.
For more information,
contact
Dirk Carrez
EP Plenary sends organic production regulation back to
Committee
The accidental presence of GMOs in
organic food, which the Commission & Council both
believe should be set at 0.9%, as is the case with
conventional food & feed, MEPs backed a 0.1% threshold
leading to a deadlock on the regulation.
For more
information, please click
here.
GM
seeds
authorised for import
and processing in animal feed
In March the Commission authorised the placing on the market of three
varieties of
GM oilseed rape. In publishing its decision,
the Commission also published an updated information package
on GM regulation in the EU.
For more information click
here
and
here
EU Parliament calls for an end to 'dormant'
patents
MEPs voted in committee in April to call on the
European Commission and member states to develop a procedure
for the abolition of 'dormant patents'. This report, due to
be adopted in plenary on 25 May, will be the EU Parliament's
response to the innovation strategy presented by the
Commission in September 2006. On patents, the EU executive
is also called on to examine possibilities to provide small
businesses with financial support to help with their patent
applications.
For more information, please click
here.
Public Consultation on
the
draft guidelines for clinical trials on
high-risk medicinal products
The European Medicines Agency’s Committee for
Medicinal Products for Human Use (CHMP) has
adopted a draft guideline on requirements for
first-in-man clinical trials for potential
high-risk medicinal products.
The draft guideline is being released for a
two-month public-consultation period.
Comments are
invited for final submission by 23 May 2007.
For more information, contact EuropaBio's
Michael Leader
or click
here
|
May 2007 |
|
24 May 2007: BIA
Seminar on clinical development of novel biological products
The programme can be found by clicking
here. EuropaBio members receive the same rate as BIA
members:
£399
rising to £499 after 30th March. For more information,
please contact Lydia Harrison,
lharrison@bioindustry.org
30 May
– 1 June 2007: European BioPerspectives 2007, Cologne /
Germany
The third conference in this
format will again unite 18 major biosciences societies and
biotech organisations in presenting an outstanding
scientific lecture programme. Leading experts from academia
and industry will address a broad range of topics from
bioinformatics, biomolecular engineering, the –omics
disciplines, molecular medicine, systems & synthetic
biology, and nanobiotechnology to the latest developments in
bioprocessing and industrial biotechnology. For more information, please
click
here.
|
June 2007 |
|
4-6 June:
International Conference Renewable Resources and Biorefineries, Ghent
Researchers, industrialists and policymakers from around
the world will gather in Ghent for the fird Renewable
resources and Biorefineries conference to discuss the future
of renewable resources and biorefineries. For more
information, please click
here.
13-15 June 2007:
New frontiers in the quality of medicines, Strasbourg
This meeting will explore international co-operation and
synergy in quality standards; the perspectives for
co-operation and partnership with regulatory agencies, the
PDG Pharmacopoeias and industry; and an action plan for the
future with recommendations from industry.
For more information, please
click
here.
14 June 2007:
EuropaBio's Open Day, Brussels, Brussels
EuropaBio's
Open
Day is an opportunity to
network at the European level, to make business connections
across Europe and to meet with
EU decision-makers and
representatives from large,
medium and small biotech companies. For more information, please
click
here.
17-19 June:
Genomics in Business 2007, Amsterdam
Genomics in Business 2007 is an international conference
that explores the business potential of genomics
applications in the agro-food biotechnology industry.
Members of EuropaBio may receive a discount of € 200 off the
prevailing registration fee. To receive the discount,
complete the online registration form
and check the box
indicating that your company is a member of EuropaBio.For
more information, please click
here.
18 June 2007: BioFinance Europe, London
A pan-European conference on alternative finance
options for bioscience companies. Organised by
the BioIndustry Association (BIA), this event will bring
senior US and European financiers together with CEOs
from some of the most innovative bioscience companies in
Europe to explore alternatives to traditional VC and
equity financing.
For more information, please
click
here.
|
September 2007 |
|
16-19
September 2007: Symbiosis, 13th European Congress on
Biotechnology, Barcelona
For more information,
please click
here
|
October 2007 |
9-11
October 2007: Biotechnica, 15th International Trade Fair,
Hanover
The event will provides an opportunity to make personal
business contacts and offers visitors an overview of the
life sciences and biotechnology. For more information,
please
click
here. |
|
|
|
    |
